| 507. |
DEVELOPMENT OF AN EPIORAL IN VITRO HUMAN TISSUE MODEL FOR ORAL IRRITANCY TESTING.
|
| 494. |
GENOMIC BIOMARKERS OF PULMONARY EXPOSURE TO TOBACCO SMOKE COMPONENTS.
|
| 483. |
AN IN VITRO APPROACH TO ASSESS THE TOXICITY OF INHALED TOBACCO SMOKE COMPONENTS: NICOTINE, CADMIUM, FORMALDEHYDE AND URETHANE.
|
| 482. |
CELLULAR RESPONSES OF PRIMARY HUMAN BRONCHIAL EPITHELIAL CELLS TO WHOLE CIGARETTE SMOKE EXPOSURE.
|
| 481. |
EXPOSURE OF A MULTI-CELLULAR IN VITRO MODEL OF HUMAN AIRWAY TISSUE TO WHOLE CIGARETTE SMOKE.
|
| 428. |
CHARACTERISATION OF AIRBORNE PARTICULATE MATTER AND RELATED MECHANISMS OF TOXICITY: AN EXPERIMENTAL APPROACH.
|
| 409. |
DRUG/XENOBIOTIC-METABOLIZING ENZYME (XME) EXPRESSION IN THE EPIAIRWAY IN VITRO HUMAN AIRWAY MODEL: UTILITY FOR ASSESSING TRACHEAL/BRONCHIAL BIOTRANSFORMATION OF INHALED PHARMACEUTICALS AND ENVIRONMENTAL CHEMICALS.
|
| 395. |
BENZO[A]PYRENE-INDUCED ORAL CARCINOGENESIS AND CHEMOPREVENTION – STUDIES IN BIOENGINEERED HUMAN TISSUE.
|
| 359. |
IDENTIFICATION OF INTELLIGENT BIOMARKERS OF EXPOSURE AND HARM IN THE RESPIRATORY EPITHELIAL TO TOBACCO SMOKE COMPONENTS.
|
| 263. |
GINGIVAL TISSUE MODEL FOR PREDICTION OF IRRITANCY OF ORAL CARE PRODUCTS.
|
